Kramer Levin adds two life sciences partners in New York

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Kramer Levin adds two life sciences partners in New York

Brian Slater and Gregory Sephton have joined Kramer Levin Naftalis & Frankel in New York. They were previously at Fitzpatrick Cella Harper & Scinto

kramer-levin-adds-two.jpg

They both have more than 20 years of experience handling patent litigation involving a broad range of technologies in the life sciences.

Slater (top right) has served as lead counsel to companies such as Gilead, Merck, and Sanofi.

Sephton (bottom right) has been involved in litigating and trying patent cases for a number of technology leaders, including Emory University, Astra Zeneca, Novartis and Warner Chilcott.

The move follows Kramer Levin’s recent hiring of Christine Willgoos, a life sciences patent litigator who came from Paul Hastings.

more from across site and SHARED ros bottom lb

More from across our site

The firm has taken the bold step of ditching the billable hour as its default pricing mechanism – watch now as rivals follow suit
The IP services provider is targeting further expansion as cost and efficiency pressures push law firms and in-house teams to rethink how they manage global portfolios
Two experienced UPC practitioners join the UK IP boutique’s growing German operation, with further recruitment planned as the firm expands in Europe
The Australian IP firm is taking on bigger rivals in Southeast Asia, betting that agility and transparent pricing can help it stand out
The firm has brought in former Weil IP leaders Doug Lumish and Jeff Homrig as it looks to deepen its patent, trade secrets and ITC bench
Bird & Bird helps GSK score a major injunction as the battle to become the UPC’s busiest division tightens, and overall filings reach a new monthly high
CEO Annette Bach explains how the Danish IP consultancy plans to build on its 65% profit growth while keeping external investment off the table for now
Belgian attorneys have revived fax systems to protect clients’ filing rights, while uncertainty over exposed patent data has left firms struggling to answer questions about the breach
In his first interview since leaving Weil Gotshal & Manges, Chris Henry explains why he returned to Latham and how he plans to bolster its tech disputes offering
As GTA VI underlines the extraordinary value of gaming franchises, lawyers at Clifford Chance say investors need to know the IP behind their next deal can deliver the growth they are paying for
Gift this article